Status:
TERMINATED
Study of the Sars-Cov2 Neuroinvasiveness - COVID19
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
COVID19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sars-Cov2 (COVID-19) may invade the CNS inducing neurological diseases such as anosmia, ageusia, encephalitis, ischemic or hemorrhagic stroke. Management of severe neurological complications in COVID-...
Eligibility Criteria
Inclusion
- COVID-19 patients requiring an external ventricular drain, a decompressive craniectomy or an intracranial hematoma surgery
Exclusion
- Pregnant or lactating women
Key Trial Info
Start Date :
June 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04427254
Start Date
June 26 2020
End Date
November 25 2022
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation A de Rothschild
Paris, France, 75019